Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
chronic heart failure (CHF) is the most frequent complication of many heart diseases; the most common one of them is coronary heart disease.
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-041-Tuesday
- By: KRASNOVA, Marina (Saint-Petersburg State Chemical-Pharmaceuitical Academy, Center of Experimental Pharmacology,, Saint-Petersburg, Russian Federation)
- Co-author(s): Dmitriy Ivkin: Center of Experimental Pharmacology, Saint-Petersburg State Chemical-Pharmaceuitical Academy, Saint-Petersburg, Russian Federation
Marina Krasnova: Center of Experimental Pharmacology, Saint-Petersburg State Chemical-Pharmaceuitical Academy, Saint-Petersburg, Russian Federation
Arina Ivkina: Center of Experimental Pharmacology, Saint-Petersburg State Chemical-Pharmaceuitical Academy, Saint-Petersburg, Russian Federation
Andrey Teslev: Saint-Petersburg State Chemical-Pharmaceuitical Academy, Saint-Petersburg, Russian Federation
Andrey Karpov: First Pavlov State Medical University of St. Peterburg, Saint-Petersburg, Russian Federation - Abstract:
Backgrounds
Chronic heart failure (CHF) is the most frequent complication of many heart diseases.Aims
Assessment of influence of 4-(oxo-3-ethoxypropanamide)benzoic acid on the development of experimental post-infarction CHF.Methods
The CHF model was reproduced by ligation of the left coronary artery in outbred male rats (post-infarction chronic heart .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023